Walter Reed Army Institute of Research 
Welcome,         Profile    Billing    Logout  
 2 Products   0 Diseases  2 Products   1 Trial   17 News 
6 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
bacteriophage therapy / BiomX
APT.DFO.001, NCT05177107: Bacteriophage Therapy in Patients With Diabetic Foot Osteomyelitis

Recruiting
2b
126
US
Phage Therapy, Placebo
Adaptive Phage Therapeutics, Inc., United States Department of Defense
Osteomyelitis, Diabetic Foot Osteomyelitis
04/24
12/24
ACTIVE2, NCT05269134: Bacteriophage Therapy in Patients With Prosthetic Joint Infections (PJI)

Withdrawn
2
90
US
Bacteriophage, Placebo
Adaptive Phage Therapeutics, Inc.
Prosthetic Joint Infection
07/25
07/27
NCT04287478: Bacteriophage Therapy in Patients With Urinary Tract Infections

Terminated
1/2
1
US
Bacteriophage Therapy
Adaptive Phage Therapeutics, Inc., United States Department of Defense
Urinary Tract Infection Bacterial
02/23
02/23
ACTIVE1, NCT05269121: Bacteriophage Therapy in First Time Chronic Prosthetic Joint Infections

Withdrawn
1/2
20
NA
Phage Therapy
Adaptive Phage Therapeutics, Inc.
Prosthetic Joint Infection, Bacterial Infections
11/23
11/24
NCT05453578: A Phase 1b/2 Trial of the Safety and Microbiological Activity of Bacteriophage Therapy in Cystic Fibrosis Subjects Colonized With Pseudomonas Aeruginosa

Completed
1/2
72
US
Placebo, WRAIR-PAM-CF1
National Institute of Allergy and Infectious Diseases (NIAID)
Bacterial Disease Carrier, Cystic Fibrosis
04/25
04/25
SARS-COV-2-Spike-Ferritin-Nanoparticle (SpFN) Vaccine / Walter Reed Army Institute of Research, USAMRIID
NCT04784767: PHASE 1 SARS-COV-2-Spike-Ferritin-Nanoparticle (SpFN) Vaccine With ALFQ Adjuvant for Prevention of COVID-19

Completed
1
29
US
25 µg SpFN_1B-06-PL + ALFQ (QS21 Adjuvant), 25 µg SpFN + ALFQ, Sodium chloride, USP, for injection (0.9% NaCl), Placebo, 50 µg SpFN_1B-06-PL + ALFQ (QS21 Adjuvant), 50 µg SpFN + ALFQ
U.S. Army Medical Research and Development Command, Walter Reed Army Institute of Research (WRAIR), Henry M. Jackson Foundation for the Advancement of Military Medicine
SARS-CoV-2 Infection
03/23
10/23
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
bacteriophage therapy / BiomX
APT.DFO.001, NCT05177107: Bacteriophage Therapy in Patients With Diabetic Foot Osteomyelitis

Recruiting
2b
126
US
Phage Therapy, Placebo
Adaptive Phage Therapeutics, Inc., United States Department of Defense
Osteomyelitis, Diabetic Foot Osteomyelitis
04/24
12/24
ACTIVE2, NCT05269134: Bacteriophage Therapy in Patients With Prosthetic Joint Infections (PJI)

Withdrawn
2
90
US
Bacteriophage, Placebo
Adaptive Phage Therapeutics, Inc.
Prosthetic Joint Infection
07/25
07/27
NCT04287478: Bacteriophage Therapy in Patients With Urinary Tract Infections

Terminated
1/2
1
US
Bacteriophage Therapy
Adaptive Phage Therapeutics, Inc., United States Department of Defense
Urinary Tract Infection Bacterial
02/23
02/23
ACTIVE1, NCT05269121: Bacteriophage Therapy in First Time Chronic Prosthetic Joint Infections

Withdrawn
1/2
20
NA
Phage Therapy
Adaptive Phage Therapeutics, Inc.
Prosthetic Joint Infection, Bacterial Infections
11/23
11/24
NCT05453578: A Phase 1b/2 Trial of the Safety and Microbiological Activity of Bacteriophage Therapy in Cystic Fibrosis Subjects Colonized With Pseudomonas Aeruginosa

Completed
1/2
72
US
Placebo, WRAIR-PAM-CF1
National Institute of Allergy and Infectious Diseases (NIAID)
Bacterial Disease Carrier, Cystic Fibrosis
04/25
04/25
SARS-COV-2-Spike-Ferritin-Nanoparticle (SpFN) Vaccine / Walter Reed Army Institute of Research, USAMRIID
NCT04784767: PHASE 1 SARS-COV-2-Spike-Ferritin-Nanoparticle (SpFN) Vaccine With ALFQ Adjuvant for Prevention of COVID-19

Completed
1
29
US
25 µg SpFN_1B-06-PL + ALFQ (QS21 Adjuvant), 25 µg SpFN + ALFQ, Sodium chloride, USP, for injection (0.9% NaCl), Placebo, 50 µg SpFN_1B-06-PL + ALFQ (QS21 Adjuvant), 50 µg SpFN + ALFQ
U.S. Army Medical Research and Development Command, Walter Reed Army Institute of Research (WRAIR), Henry M. Jackson Foundation for the Advancement of Military Medicine
SARS-CoV-2 Infection
03/23
10/23

Download Options